What Happened?
Philadelphia, PA-based Carisma-Therapeutics Appointed Richard Morris as Chief Financial Officer
About the Company
Carisma Therapeutics Inc. is a clinical stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors. Carisma Therapeutics is headquartered in Philadelphia, PA.
About the Person
Richard Morris is Chief Financial Officer at Carisma Therapeutics. Previously, Richard held various senior HR leadership roles in the industry.
Info Source
News
Short Profile